Lynne Strasfeld, MD

Lynne Strasfeld, MD

Lynne Strasfeld, MD
Associate Professor of Medicine
Program Director, OHSU Infectious Disease Fellowship
Division of Infectious Diseases, OHSU


B.S., Cornell University, 1992
M.D., Yale University School of Medicine, 1996


Internal Medicine - New York Presbyterian/Weill Cornell Medical Center, 1999
Medical Chief Resident - New York Presbyterian/Weill Cornell Medical Center, 2003


Infectious Diseases, Albert Einstein College of Medicine/Montefiore Medical Center (Bronx, NY), 2002

Clinical interests

Infections in transplant recipients and other immunocompromised hosts

Research interests

Prevention of opportunistic and healthcare associated infections in transplant recipient

Representative publications

  1. Maziarz RT, Brazauskas R, Chen M, McLeod AA, Martino R, Wingard JR, Aljurf M, Battiwalla M, Dvorak CC, Geroge B, Guinan EC, Hale GA, Lazarus HM, Lee JW, Liesveld JL, Ramanathan M, Reddy V, Savani BN, Smith FO, Strasfeld L, Taplitz RA, Ustun C, Boeckh MJ, Gea-Banacloche J, Lindemans CA, Auletta JJ, Riches ML. Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study. Bone Marrow Transplant 2017:52(2):270-278.
  2. Young JH, Logan BR, Wu J, Wingard JR, Weisdorf DJ, Mudrick C, Knust K, Horowitz MM, Confer DL, Dubberke ER, Pergam SA, Marty FM, Strasfeld LM, Brown JW, Langston AA, Schuster MG, Kaul DR, Martin SI, Anasetti C. Infections following Transplantation of Bone Marrow or Peripheral-Blood Stem Cells from Unrelated Donors. Biol Blood Marrow Transplant 2016;22(2):359-370.
  3. Hakki M, Strasfeld LM, Townes JM. Predictive value of testing nasopharyngeal samples for respiratory viruses in the setting of lower respiratory tract disease. J Clin Microbiol 2014;52(11):4020-4022.
  4. Chou S, Ercolani R, Sahoo MK, Lefterova MI, Strasfeld L, Pinsky BA. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by next-generation sequencing. Antimicrob Agents Chemother 2014;58(8):4697-4702.
  5. Strasfeld L, Espinosa-Aguilar L, Gajewski JL, Stenzel P, Agustin P, Mater E, Maziarz RT. Emergence of Cunninghamella as a highly pathogenic invasive mould infection in allogeneic transplant recipients. Clin Lymphoma Myeloma Leuk 2013;13(5):622-628.
  6. Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young JA, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M;for the Maribavir 1263-300 Clinical Study Group. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomized trial. Lancet Infect Dis 2011;11(4):284-292.
  7. Espinosa-Aguilar L, Green JG, Forrest GN, Maziarz RT, Strasfeld L, Taplitz RA. Novel H1N1 influenza in hematopoietic stem cell transplant recipients: two center's experience. Biol Blood Marrow Transplant 2010;17(4):566-573.